Galactooligosaccharides (GOS) 用于 Irritable Bowel Syndrome (IBS)

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dgalactooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

结论

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

Key Study Findings

Review

Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal …

Dose: None vs: None Outcome: None 效果: None None

研究人群: review of prebiotics, probiotics, synbiotics, postbiotics for gastrointestinal inflammation

Randomized Controlled Trial n=45 12 weeks Double-blind

All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable …

Dose: None vs: Sequential FODMAP subgroup reintroduction Outcome: Abdominal pain and bloating severity 效果: None p=0.007 fructans; p=0.04 GOS

研究人群: IBS patients (Rome IV) who improved on FODMAP diet

Randomized Controlled Trial 4 weeks Double-blind

Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized …

Dose: None vs: Traditional low FODMAP diet Outcome: IBS symptom response 效果: None None

研究人群: IBS-D patients (Rome IV)

Systematic Review

Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …

Dose: None vs: Various Outcome: IBS symptom improvement 效果: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

研究人群: Adult IBS patients

Randomized Controlled Trial n=34 8 weeks Single-blind

A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation …

Dose: 9.2 g/day total (4.6 g twice daily) vs: Maltodextrin 9.2 g/day placebo Outcome: IBS-SSS score and IBS-QoL score 效果: IBS-SSS: 267.3→195.8; IBS-QoL: 61.0→77.4 0.026 (IBS-SSS); 0.006 (QoL)

研究人群: Adults with constipation-predominant IBS

Other

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.

Dose: None vs: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers 效果: Up to 99.5% FODMAP reduction (wheat malt) None

研究人群: Laboratory food science study (no human subjects)

Key Statistics

研究数量

400

受试者

↑

Positive

等级

Referenced Papers

Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal inflammation. Review

Food research international … 2026

Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial. RCT

Clinical gastroenterology and … 2025 19 次引用

All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome. RCT

Clinical gastroenterology and … 2025 12 次引用

Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical … Systematic Review

Nutrition reviews 2025 10 次引用

Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating Mast Cell Hyperactivation. Other

Nutrients 2025 6 次引用

FODMAP Profile of Wholegrain Pasta. Other

Foods (Basel, Switzerland) 2025 3 次引用

A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation predominant IBS. RCT

Scientific reports 2025 2 次引用

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers. Other

Foods (Basel, Switzerland) 2025 1 次引用

Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential. Review

International journal of … 2025

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study. Other

Gastroenterology research and … 2025

A non-pharmacological intervention for insomnia: tryptophan-fructooligosaccharides combination improves sleep in mice via anti-inflammation and gut microbiota modulation. Other

Food & function 2025

Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome. RCT

Gastroenterology 2024 24 次引用

FODMAP reduction strategies for nutritionally valuable baking products: current state and future challenges. Review

Critical reviews in … 2024 7 次引用

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … Other

Journal of clinical … 2024 4 次引用

Postbiotics: A new member in the biotics family. Other

Archivos argentinos de … 2024 3 次引用

Laboratory domestication of Lactiplantibacillus plantarum alters some phenotypic traits but causes non-novel genomic impact. Other

Journal of applied … 2024 1 次引用

Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial. Other

Gastro hep advances 2024 1 次引用

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Other

Frontiers in nutrition 2023 8 次引用

Food contributing to fermentable oligosaccharide, disaccharide, monosaccharide, and polyols intake in Korean adults. Other

Nutrition research and … 2023 2 次引用

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … Other

Voprosy pitaniia 2023

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 次引用

Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome. Review

American journal of … 2022 18 次引用

Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts. Other

FASEB journal : … 2022 16 次引用

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of … Other

Journal of clinical … 2022 12 次引用

The challenges of implementing low fermentable oligo-, di-, mono-saccharides and polyol diet in India: An analysis of available data. Other

Indian journal of … 2022 11 次引用

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal … RCT

Nutrients 2022 8 次引用

Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Other

Expert review of … 2022 8 次引用

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Other

Food chemistry: X 2021 64 次引用

Best management of irritable bowel syndrome. Review

Frontline gastroenterology 2021 56 次引用

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel … RCT

Nutrients 2021 36 次引用

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation. Other

Foods (Basel, Switzerland) 2021 10 次引用

FODMAP Consumption by Adults from the French Population-Based NutriNet-Santé Cohort. Other

The Journal of … 2021 6 次引用

Dietary interventions and irritable bowel syndrome - what really works? Review

Current opinion in … 2021 6 次引用

A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome … RCT

Neurogastroenterology and motility 2021 4 次引用

Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease … RCT

Gastroenterology 2020 290 次引用

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … RCT

Nutrients 2020 78 次引用

β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. RCT

The American journal … 2020 75 次引用

Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. CCT

Nutrition research (New … 2020 42 次引用

Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa. Other

Gastroenterology 2020 41 次引用

Variability in yeast invertase activity determines the extent of fructan hydrolysis during wheat dough fermentation and final FODMAP levels in … Other

International journal of … 2020 30 次引用

Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management? RCT

European journal of … 2020 20 次引用

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Other

Journal of the … 2019 171 次引用

Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled … Meta-Analysis

The American journal … 2019 108 次引用

Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to … Review

Alimentary pharmacology & … 2019 36 次引用

Processing methods for reducing alpha-galactosides in pulses. Review

Critical reviews in … 2019 35 次引用

Technological Methods for Reducing the Content of Fructan in Wheat Bread. Other

Foods (Basel, Switzerland) 2019 21 次引用

Influence of Dietary Restriction on Irritable Bowel Syndrome. Review

The American journal … 2019 15 次引用

Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. RCT

Clinical gastroenterology and … 2018 100 次引用

Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment. RCT

The American journal … 2018 49 次引用

Impact of Cultivation Method and Cultivar Selection on Soluble Carbohydrates and Pungent Principles in Onions ( Allium cepa L.). Other

Journal of agricultural … 2018 13 次引用

Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. Review

Journal of gastroenterology … 2017 255 次引用

FODMAPs: food composition, defining cutoff values and international application. Review

Journal of gastroenterology … 2017 181 次引用

Dietary fiber in irritable bowel syndrome (Review). Other

International journal of … 2017 146 次引用

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 次引用

Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. RCT

Journal of Crohn's … 2017 122 次引用

When the low FODMAP diet does not work. Review

Journal of gastroenterology … 2017 32 次引用

Irritable bowel syndrome and diet: where are we in 2018? Review

Current opinion in … 2017 24 次引用

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. RCT

Nutrition journal 2017 10 次引用

Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome? Other

Alimentary pharmacology & … 2017

Diet and nutritional factors in inflammatory bowel diseases. Review

World journal of … 2016 238 次引用

Does oral α-galactosidase relieve irritable bowel symptoms? RCT

Scandinavian journal of … 2016 17 次引用

[Non-allergic gluten sensitivity. A controversial disease - or not yet sufficiently explored?]. Other

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2016 2 次引用

The Low FODMAP Diet and Its Application in East and Southeast Asia. Other

Journal of neurogastroenterology … 2015 60 次引用

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. RCT

The Journal of … 2012 558 次引用

Health benefits of probiotics and prebiotics in women. Review

Menopause international 2009 29 次引用

Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized … RCT

Journal of clinical … 2008 73 次引用

Review article: prebiotics in the gastrointestinal tract. Review

Alimentary pharmacology & … 2006 629 次引用

Beneficial health effects of low-digestible carbohydrate consumption. Review

The British journal … 2001 166 次引用

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. RCT

The American journal … 2000 136 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:: 2.5-5 g/day
ibssupport:: 3.5 g/day (optimal dose; higher doses may increase symptoms)
infantgutsupport:: 0.24-0.48 g/100 mL formula (added to infant formula)

上限： Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

研究中使用的剂量

剂量	持续时间	效果	N
None	--	Positive	--
None	12 weeks	Negative	45
None	4 weeks	Mixed	--
None	--	Positive	--
9.2 g/day total (4.6 g twice daily)	8 weeks	Positive	34
None	--	Positive	--
1e9 CFU/day + GOS 10 g/L	--	Positive	--
None	--	Neutral	--

最佳服用时间： With meals; start with lower dose and increase gradually

Safety & Side Effects

已报告的副作用

⚠ Gas and bloating (especially above 5 g/day; dose-response is U-shaped)
⚠ Flatulence at higher doses
⚠ Abdominal cramping if dose increased too quickly
⚠ May worsen symptoms in FODMAP-sensitive individuals

已知相互作用

● Other FODMAPs (cumulative fermentation in sensitive individuals)
● Lactose-containing products (GOS is derived from lactose; generally safe for lactose-intolerant individuals as GOS itself is lactose-free)

可耐受最高摄入量： Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Galactooligosaccharides (GOS) help with Irritable Bowel Syndrome (IBS)?

Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Galactooligosaccharides (GOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).

How much Galactooligosaccharides (GOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2.5-5 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Galactooligosaccharides (GOS)?

Reported side effects may include Gas and bloating (especially above 5 g/day; dose-response is U-shaped), Flatulence at higher doses, Abdominal cramping if dose increased too quickly, May worsen symptoms in FODMAP-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Galactooligosaccharides (GOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

其他成分用于 Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

快速结论

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

Evidence Strength72%

High confidence

研究分析

RCT (20)Meta (1)Other (0)

对比替代方案

查看其他成分针对该健康状况的对比结果。

查看所有成分用于 Irritable Bowel Syndrome (IBS)

了解更多

FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。